According to our (Global Info Research) latest study, the global Exosome SEC Column market size was valued at US$ 525 million in 2025 and is forecast to a readjusted size of US$ 1331 million by 2032 with a CAGR of 14.2% during review period.
An Exosome SEC Column (Size Exclusion Chromatography Column) is a chromatographic tool specifically designed to isolate and purify exosomes based on their size. It separates particles by allowing smaller molecules (such as proteins and salts) to enter the porous matrix inside the column and be retained longer, while larger vesicles like exosomes are excluded from the pores and elute earlier. This method preserves the structural integrity and biological activity of exosomes, making it widely used in extracellular vesicle research and downstream applications.In 2025, global Exosome SEC Column production reached approximately 2.43 M units, with an average global market price of around US$ 210 per unit. Annual production capacity is 2.95 M units. Gross Profit Margin: 68%.The Exosome SEC Column industry chain is structured into three main layers. The upstream segment includes chromatography resin and material suppliers such as agarose, dextran, and polymer bead manufacturers, which determine the core separation performance of the column. The midstream consists of SEC column manufacturers and EV isolation kit developers who design, pack, and validate the final products for laboratory and clinical use. The downstream includes pharmaceutical companies, CROs, academic research institutes, and diagnostic laboratories that apply SEC columns for exosome purification, biomarker discovery, and liquid biopsy workflows.Exosome SEC Columns represent a high-growth but structurally specialized niche within the broader life science tools industry. Their value lies not in high unit volume but in increasing adoption in EV-based diagnostics and therapeutic development. In my view, the market is still transitioning from research-use dominance toward early clinical and industrial applications, meaning standardization and scalability will be the key drivers of long-term competition rather than price alone.
This report is a detailed and comprehensive analysis for global Exosome SEC Column market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Processing Capacity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Exosome SEC Column market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Exosome SEC Column market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Exosome SEC Column market size and forecasts, by Processing Capacity and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Exosome SEC Column market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Exosome SEC Column
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Exosome SEC Column market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, Thermo Fisher Scientific, Merck Kgaa, Danaher Corporation, Bio-Rad Laboratories, Agilent Technologies, Waters Corporation, Tosoh Bioscience, Shimadzu Corporation, Izon Science, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Exosome SEC Column market is split by Processing Capacity and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Processing Capacity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Processing Capacity
Micro-scale SEC Column (<1 mL sample)
Small-scale SEC Column (1–10 mL sample)
Medium-scale SEC Column (10–100 mL sample)
Large-scale SEC Column (>100 mL sample)
Market segment by Column Format
Spin Column
Gravity Column
FPLC Column
Market segment by Sample Type
Plasma/Serum Exosome SEC Column
Cell Culture Media SEC Column
Urine Exosome SEC Column
Multi-sample Universal SEC Column
Market segment by Application
Pharmaceutical
Clinical
Research
Others
Major players covered
Cytiva
Thermo Fisher Scientific
Merck Kgaa
Danaher Corporation
Bio-Rad Laboratories
Agilent Technologies
Waters Corporation
Tosoh Bioscience
Shimadzu Corporation
Izon Science
Nanoeast Biotechnology
Beijing Origene Technologies
Shanghai Excell Bio
Sepax Technologies
Sartorius AG
Repligen Corporation
Phenomenex
Purolite
Shimadzu Bio-Science Division
Bio-Techne Corporation
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Exosome SEC Column product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Exosome SEC Column, with price, sales quantity, revenue, and global market share of Exosome SEC Column from 2021 to 2026.
Chapter 3, the Exosome SEC Column competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Exosome SEC Column breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Processing Capacity and by Application, with sales market share and growth rate by Processing Capacity, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Exosome SEC Column market forecast, by regions, by Processing Capacity, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Exosome SEC Column.
Chapter 14 and 15, to describe Exosome SEC Column sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Exosome SEC Column. Industry analysis & Market Report on Exosome SEC Column is a syndicated market report, published as Global Exosome SEC Column Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Exosome SEC Column market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.